Login / Signup

Imatinib and CAR T cell therapy enable sustained response in a young patient with refractory RCSD1-ABL1-positive acute lymphoblastic leukemia.

Yajuan CuiHong-Ling Peng
Published in: Annals of hematology (2023)
Keyphrases
  • cell therapy
  • acute lymphoblastic leukemia
  • chronic myeloid leukemia
  • stem cells
  • mesenchymal stem cells
  • case report
  • allogeneic hematopoietic stem cell transplantation
  • tyrosine kinase
  • middle aged
  • bone marrow